Full text is available at the source.
Abstract
Longer-term outcome and safety data of repeated subcutaneous racemic ketamine for treatment-resistant depression is lacking.
- The effects of prior ketamine treatment on subsequent response in treatment-resistant depression remain unclear.
- Limited data exists regarding the safety profile of repeated subcutaneous racemic ketamine administration.
- Further investigation is needed to understand the long-term outcomes associated with this treatment approach.
Simplified